These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26976886)

  • 1. Chronic Chagas Disease Diagnosis: A Comparative Performance of Commercial Enzyme Immunoassay Tests.
    Santos FL; de Souza WV; Barros Mda S; Nakazawa M; Krieger MA; Gomes Yde M
    Am J Trop Med Hyg; 2016 May; 94(5):1034-9. PubMed ID: 26976886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
    Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
    Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of seven diagnostic tests to detect Trypanosoma cruzi infection in patients in chronic phase of Chagas disease.
    Duarte LF; Flórez O; Rincón G; González CI
    Colomb Med (Cali); 2014; 45(2):61-6. PubMed ID: 25100890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reactivity of GST-SAPA antigen of Trypanosoma cruzi against sera from patients with Chagas disease and leishmaniasis].
    Gil J; Cimino R; López Quiroga I; Cajal S; Acosta N; Juarez M; Zacca R; Orellana V; Krolewiecki A; Diosque P; Nasser J
    Medicina (B Aires); 2011; 71(2):113-9. PubMed ID: 21550926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of conventional and non-conventional serological tests for the diagnosis of imported Chagas disease in Spain].
    Flores-Chávez M; Cruz I; Rodríguez M; Nieto J; Franco E; Gárate T; Cañavate C
    Enferm Infecc Microbiol Clin; 2010 May; 28(5):284-93. PubMed ID: 19962790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary evaluation of the commercial kit Chagas ( Trypanosoma cruzi ) IgG-ELISA ® in Colombian individuals].
    Llano M; Pavía P; Flórez AC; Cuéllar A; González JM; Puerta C
    Biomedica; 2014; 34(2):228-36. PubMed ID: 24967928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Field evaluation of four novel enzyme immunoassays for Chagas' disease in Venezuela blood banks: comparison of assays using fixed-epimastigotes, fixed-trypomastigotes or trypomastigote excreted-secreted antigens from two Trypanosoma cruzi strains.
    Berrizbeitia M; Ndao M; Bubis J; Gottschalk M; Aché A; Lacouture S; Medina M; Ward BJ
    Transfus Med; 2006 Dec; 16(6):419-31. PubMed ID: 17163873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inconclusive results in conventional serological screening for Chagas' disease in blood banks: evaluation of cellular and humoral response.
    Furuchó CR; Umezawa ES; Almeida I; Freitas VL; Bezerra R; Nunes EV; Sanches MC; Guastini CM; Teixeira AR; Shikanai-Yasuda MA
    Trop Med Int Health; 2008 Dec; 13(12):1527-33. PubMed ID: 18983272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides.
    Ferreira AW; Belem ZR; Lemos EA; Reed SG; Campos-Neto A
    J Clin Microbiol; 2001 Dec; 39(12):4390-5. PubMed ID: 11724850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assay and polymerase chain reaction performance using Mexican and Guatemalan discrete typing unit I strains of Trypanosoma cruzi.
    Ballinas-Verdugo M; Reyes PA; Mejia-Dominguez A; López R; Matta V; Monteón VM
    Vector Borne Zoonotic Dis; 2011 Dec; 11(12):1569-75. PubMed ID: 21867413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter comparative study of the performance of four rapid immunochromatographic tests for the detection of anti-
    Iturra JAD; Leony LM; Medeiros FAC; de Souza Filho JA; Siriano LDR; Tavares SB; Luquetti AO; Belo VS; de Sousa AS; Santos FLN
    Front Med (Lausanne); 2023; 10():1031455. PubMed ID: 36936214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients.
    Hernández-Becerril N; Nava A; Reyes PA; Monteón VM
    Arch Cardiol Mex; 2001; 71(3):199-205. PubMed ID: 11665655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease.
    Vicco MH; Ferini F; Rodeles L; Cardona P; Bontempi I; Lioi S; Beloscar J; Nara T; Marcipar I; Bottasso OA
    Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):791-6. PubMed ID: 24773859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-epitope proteins for improved serological detection of Trypanosoma cruzi infection and Chagas Disease.
    Duthie MS; Guderian JA; Vallur AC; Misquith A; Liang H; Mohamath R; Luquetti AO; Carter D; Tavares SN; Reed SG
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):191-6. PubMed ID: 26658314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inexpensive antigen for serodiagnosis of Chagas' disease.
    Briceño L; Rodríguez EM; Medina M; Campos Y; Mosca W; Briceño A; León G
    Invest Clin; 2010 Mar; 51(1):101-13. PubMed ID: 20815160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency of Trypanosoma cruzi infection in patients with implanted pacemaker].
    Mora G; Echeverry MC; Rey GE; López MC; Posada LF; Rivas FA
    Biomedica; 2007 Dec; 27(4):483-9. PubMed ID: 18320115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease.
    Gironès N; Rodríguez CI; Basso B; Bellon JM; Resino S; Muñoz-Fernández MA; Gea S; Moretti E; Fresno M
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1039-43. PubMed ID: 11687436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of an optimized non-conventional flow cytometry method to detect anti-Trypanosoma cruzi immunoglobulin G for the serological diagnosis and cure assessment following chemotherapeutic treatment of Chagas disease.
    Matos CS; Coelho-Dos-Reis JG; Rassi A; Luquetti AO; Dias JC; Eloi-Santos SM; Gomes IT; Vitelli-Avelar DM; Wendling AP; Rocha RD; Teixeira-Carvalho A; Peruhype-Magalhães V; Andrade MC; Martins-Filho OA
    J Immunol Methods; 2011 Jun; 369(1-2):22-32. PubMed ID: 21477591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of real time PCR to quantify parasite load in serum samples from chronic Chagas disease patients.
    Melo MF; Moreira OC; Tenório P; Lorena V; Lorena-Rezende I; Júnior WO; Gomes Y; Britto C
    Parasit Vectors; 2015 Mar; 8():154. PubMed ID: 25890282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of full-length recombinant calflagin and its c fragment for improvement of diagnosis of Trypanosoma cruzi infection.
    Marcipar IS; Roodveldt C; Corradi G; Cabeza ML; Brito ME; Winter LM; Marcipar AJ; Silber AM
    J Clin Microbiol; 2005 Nov; 43(11):5498-503. PubMed ID: 16272476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.